STWX:SW:SW-SPDR® MSCI Europe Health Care UCITS ETF CHF (CHF)

ETF | Others |

Last Closing

USD 223.1

Change

-2.70 (-1.20)%

Market Cap

USD 0.69B

Volume

24.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHSRIA:SW UBS ETF (CH) MSCI Switzerland ..

+0.12 (+0.57%)

USD 492,935.36B
XLDX:SW Xtrackers LevDAX Daily Swap UC..

+1.20 (+0.70%)

USD 411,075.38B
CHSRI:SW UBS ETF (CH) - MSCI Switzerlan..

+0.15 (+0.85%)

USD 368,190.74B
XNIF:SW Xtrackers Nifty 50 Swap UCITS ..

+0.90 (+0.36%)

USD 292,109.69B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.10 (+0.45%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.05 (+0.18%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

+78.00 (+1.10%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+3.50 (+0.07%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+1.40 (+0.09%)

USD 134,034.86B

ETFs Containing STWX:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.41% 89% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.41% 89% A- 88% B+
Trailing 12 Months  
Capital Gain 16.27% 75% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.27% 75% C 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.75% 53% F 53% F
Dividend Return 2.75% 53% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.65% 62% D 66% D+
Risk Adjusted Return 59.07% 57% F 61% D-
Market Capitalization 0.69B 69% C- 65% D

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike